These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33909465)

  • 41. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
    Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
    J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Abbreviated breast MRI combining FAST protocol and high temporal resolution (HTR) dynamic contrast enhanced (DCE) sequence.
    Milon A; Vande Perre S; Poujol J; Trop I; Kermarrec E; Bekhouche A; Thomassin-Naggara I
    Eur J Radiol; 2019 Aug; 117():199-208. PubMed ID: 31307648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of Breast Cancer Morphology Using Diffusion-Weighted and Dynamic Contrast-Enhanced MRI: Intermethod and Interobserver Agreement.
    Radovic N; Ivanac G; Divjak E; Biondic I; Bulum A; Brkljacic B
    J Magn Reson Imaging; 2019 May; 49(5):1381-1390. PubMed ID: 30325549
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor metabolism and perfusion ratio assessed by 18F-FDG PET/CT and DCE-MRI in breast cancer patients: Correlation with tumor subtype and histologic prognostic factors.
    An YS; Kang DK; Jung YS; Han S; Kim TH
    Eur J Radiol; 2015 Jul; 84(7):1365-70. PubMed ID: 25886700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic performance of maximum slope: A kinetic parameter obtained from ultrafast dynamic contrast-enhanced magnetic resonance imaging of the breast using k-space weighted image contrast (KWIC).
    Ohashi A; Kataoka M; Kanao S; Iima M; Murata K; Weiland E; Onishi N; Kawai M; Toi M; Togashi K
    Eur J Radiol; 2019 Sep; 118():285-292. PubMed ID: 31324411
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dynamic contrast-enhanced MRI of the breast: quantitative method for kinetic curve type assessment.
    El Khouli RH; Macura KJ; Jacobs MA; Khalil TH; Kamel IR; Dwyer A; Bluemke DA
    AJR Am J Roentgenol; 2009 Oct; 193(4):W295-300. PubMed ID: 19770298
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Artificial Intelligence Applied to Breast MRI for Improved Diagnosis.
    Jiang Y; Edwards AV; Newstead GM
    Radiology; 2021 Jan; 298(1):38-46. PubMed ID: 33078996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship of temporal resolution to diagnostic performance for dynamic contrast enhanced MRI of the breast.
    El Khouli RH; Macura KJ; Barker PB; Habba MR; Jacobs MA; Bluemke DA
    J Magn Reson Imaging; 2009 Nov; 30(5):999-1004. PubMed ID: 19856413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA; Cutajar M; Gordon I
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ultrafast dynamic contrast-enhanced breast MRI: association with pathologic complete response in neoadjuvant treatment of breast cancer.
    Kim JH; Park VY; Shin HJ; Kim MJ; Yoon JH
    Eur Radiol; 2022 Jul; 32(7):4823-4833. PubMed ID: 35064805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Digital reference object toolkit of breast DCE MRI for quantitative evaluation of image reconstruction and analysis methods.
    Bae J; Tan Z; Solomon E; Huang Z; Heacock L; Moy L; Knoll F; Kim SG
    Magn Reson Med; 2024 Oct; 92(4):1728-1742. PubMed ID: 38775077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravoxel incoherent motion diffusion-weighted imaging as an adjunct to dynamic contrast-enhanced MRI to improve accuracy of the differential diagnosis of benign and malignant breast lesions.
    Ma D; Lu F; Zou X; Zhang H; Li Y; Zhang L; Chen L; Qin D; Wang B
    Magn Reson Imaging; 2017 Feb; 36():175-179. PubMed ID: 27742437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The kinetic analysis of breast cancer: An investigation of the optimal temporal resolution for dynamic contrast-enhanced MR imaging.
    Matsukuma M; Furukawa M; Yamamoto S; Nakamura K; Tanabe M; Okada M; Iida E; Ito K
    Clin Imaging; 2020 May; 61():4-10. PubMed ID: 31945688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of dynamic contrast-enhanced MRI in evaluating the association between contralateral parenchymal enhancement and survival outcome in ER-positive, HER2-negative, node-negative invasive breast cancer.
    Shin GW; Zhang Y; Kim MJ; Su MY; Kim EK; Moon HJ; Yoon JH; Park VY
    J Magn Reson Imaging; 2018 Dec; 48(6):1678-1689. PubMed ID: 29734483
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Separation of benign and malignant breast lesions using dynamic contrast enhanced MRI in a biopsy cohort.
    Kim SG; Freed M; Leite APK; Zhang J; Seuss C; Moy L
    J Magn Reson Imaging; 2017 May; 45(5):1385-1393. PubMed ID: 27766710
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
    Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
    Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Model-Free and Model-based Parameters Derived From CAIPIRINHA-Dixon-TWIST-VIBE DCE-MRI: Associations With Prognostic Factors and Molecular Subtypes of Invasive Ductal Breast Cancer.
    Xie T; Jiang T; Zhao Q; Fu C; Nickel MD; Peng W; Gu Y
    J Magn Reson Imaging; 2023 Jul; 58(1):81-92. PubMed ID: 36433714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Feasibility analysis of early temporal kinetics as a surrogate marker for breast tumor type, grade, and aggressiveness.
    Heacock L; Lewin AA; Gao Y; Babb JS; Heller SL; Melsaether AN; Bagadiya N; Kim SG; Moy L
    J Magn Reson Imaging; 2018 Jun; 47(6):1692-1700. PubMed ID: 29178258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Performance evaluation of texture analysis based on kinetic parametric maps from breast DCE-MRI in classifying benign from malignant lesions.
    Jiang Z; Yin J
    J Surg Oncol; 2020 Jun; 121(8):1181-1190. PubMed ID: 32167588
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diffusion-weighted imaging and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer: Correlation of the apparent diffusion coefficient and maximum standardized uptake values with prognostic factors.
    Karan B; Pourbagher A; Torun N
    J Magn Reson Imaging; 2016 Jun; 43(6):1434-44. PubMed ID: 26663655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.